Farther Finance Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $360K | Buy |
12,159
+1,068
| +10% | +$31.6K | 0.01% | 1081 |
|
|
2025
Q1 | $326K | Buy |
11,091
+477
| +4% | +$14K | 0.01% | 1001 |
|
|
2024
Q4 | $304K | Sell |
10,614
-1,064
| -9% | -$30.5K | 0.01% | 801 |
|
|
2024
Q3 | $451K | Buy |
11,678
+11,466
| +5,408% | +$443K | 0.02% | 634 |
|
|
2024
Q2 | $6.92K | Buy |
212
+169
| +393% | +$5.51K | ﹤0.01% | 2241 |
|
|
2024
Q1 | $1.67K | Hold |
43
| – | – | ﹤0.01% | 2560 |
|
|
2023
Q4 | $1.32K | Sell |
43
-57
| -57% | -$1.76K | ﹤0.01% | 2615 |
|
|
2023
Q3 | $2.24K | Hold |
100
| – | – | ﹤0.01% | 1814 |
|
|
2023
Q2 | $2.15K | Hold |
100
| – | – | ﹤0.01% | 1728 |
|
|
2023
Q1 | $2.4K | Hold |
100
| – | – | ﹤0.01% | 1573 |
|
|
2022
Q4 | $2.32K | Buy |
+100
| New | +$2.32K | ﹤0.01% | 1400 |
|